Open Orphan #ORPH – Update on antibody test agreement and recent share price movement

Open Orphan plc (ORPH) the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is the world leader in the testing of vaccines and antivirals using human challenge study models, notes the increase in the Company’s share price and media comment regarding its collaboration with Quotient Limited. Furthermore, it […]

Open Orphan #ORPH & Cadence Minerals #KDNC on the Vox Markets podcast

   Cathal Friel, Executive Chairman of Open Orphan (ORPH) talks about the major new contract they’ve signed with a US biotechnology company. Kiran Morzaria CEO of Cadence Minerals (KDNC) provides an update on operations at their Amapá project. Interview starts at 24 minutes 40 seconds. Link here to listen

Irish Independent – Open Orphan subsidiary starts testing drug for treating Covid-19

by Ellie Donnelly A subsidiary of Open Orphan has started testing a drug that could potentially treat Covid-19. Open Orphan is a Europe- focused pharma services company specialising in rare disease and so-called orphan drugs. The tests are being carried out by its London-based subsidiary Hvivo on behalf of its client Nearmedic International. The drug […]